Database

EFFIMUNE

Solution provided
Technology
Supplier identity
General description

Effimune is a Biotech Company dedicated to immunomodulation in autoimmunity, transplantation and cancer.

Effimune is developing the first biotechnology drug that selectively blocks effector T cells and enhances regulatory T cells. The first product of the company, a first in class has the potential to restore the immune tolerance which is deficient in patients suffering from some autoimmune diseases or after organ or cells transplantation.

 

Region
Regions of Pays de la Loire, Centre and Poitou-Charentes, FR
Regional access broker
  • Grégory Bauer, Atlanpole Biotherapies
Activity description
Services provided

FR104 : a Tcell antagonist monovalent anti CD28 -  Effi7-h : Cytotoxic Mab anti CD127- MP196 : Mab anti IL23

Training and Staff possibilities
No
Contact information
Name
HIANCE
Surname
Maryvonne
Function
CEO
Phone number
+33 (0) 2 40 41 28 34
Address
Faculté de Médecine
1 rue Gaston Veil
44035  NANTES
France